Compound Detail

CHEMBL5412160

Enter ChEMBL ID:

Free Research Context This compound will appear in recent viewed items on the research home for this browser.

CCC(=O)Nc1cccc(Nc2cc(Nc3cccc(OC)c3)ncn2)c1

ChEMBL ↗ Properties Compare Identifier

Basic Information

ChEMBL ID	CHEMBL5412160
Phase	Preclinical
Structure Type	MOL
InChI Key	UIBWFWGRZIRAPL-UHFFFAOYSA-N

Targets

Activities

Assay Types

PK Parameters

Publications

Known Names

363.4

MW (Da)

4.32

ALogP

HBA

HBD

88.2

PSA (Å²)

0.58

QED

Ro5 Violations

Rot. Bonds

Availability	Unknown
Chirality	Unknown

First in Class Prodrug

IC50 5 meas. best 8.17

Target	Type	Best pChEMBL	Mean pChEMBL	Best (nM)	# Data
HeLa CHEMBL399	IC50	8.17	8.17	6.7	1
SK-OV-3 CHEMBL614925	IC50	7.85	7.85	14.1	1
HepG2 CHEMBL395	IC50	7.0	7.0	99.3	1
A549 CHEMBL392	IC50	6.56	6.56	273.1	1
B16-F10 CHEMBL612656	IC50	6.41	6.41	392.5	1

Top measurements by pChEMBL value

Target	Type	Rel.	Value	Units	pChEMBL	Assay	PubMed
HeLa	IC50	=	6.7	nM	8.17	Antiproliferative activity against human HeLa cells assessed as inhibition of ce...	36621138
SK-OV-3	IC50	=	14.1	nM	7.85	Antiproliferative activity against human SK-OV-3 cells assessed as inhibition of...	36621138
HepG2	IC50	=	99.3	nM	7.0	Antiproliferative activity against human HepG2 cells assessed as inhibition of c...	36621138
A549	IC50	=	273.1	nM	6.56	Antiproliferative activity against human A549 cells assessed as inhibition of ce...	36621138
B16-F10	IC50	=	392.5	nM	6.41	Antiproliferative activity against mouse B16-F10 cells assessed as inhibition of...	36621138

PubMed	DOI	Target Context	# Activities
36621138	10.1016/j.ejmech.2022.115085	SK-OV-3	1
36621138	10.1016/j.ejmech.2022.115085	HepG2	1
36621138	10.1016/j.ejmech.2022.115085	MDA-MB-231	1
36621138	10.1016/j.ejmech.2022.115085	HeLa	1
36621138	10.1016/j.ejmech.2022.115085	B16-F10	1
36621138	10.1016/j.ejmech.2022.115085	A549	1

Data from ChEMBL 36 via Core Engine